
China Rx
Kurzinformation



inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
With a New Epilogue by co-author Rosemary Gibson. Millions of Americans are taking prescription drugs made in China and don't know it--and pharmaceutical companies are not eager to tell them. This is a disturbing, well-researched wake-up call for improving the current system of drug supply and manufacturing.Several decades ago, penicillin, vitamin C, and many other prescription and over-the-counter products were manufactured in the United States. But with the rise of globalization, antibiotics, antidepressants, birth control pills, blood pressure medicines, cancer drugs, among many others are made in China and sold in the United States. China's biggest impact on the US drug supply is making essential ingredients for thousands of medicines found in American homes and used in hospital intensive care units and operating rooms. The authors convincingly argue that there are at least two major problems with this scenario. First, it is inherently risky for the United States to become dependent on any one country as a source for vital medicines, especially given the uncertainties of geopolitics. For example, if an altercation in the South China Sea causes military personnel to be wounded, doctors may rely upon medicines with essential ingredients made by the adversary. Second, lapses in safety standards and quality control in Chinese manufacturing are a risk. Citing the concerns of FDA officials and insiders within the pharmaceutical industry, the authors document incidents of illness and death caused by contaminated medications that prompted reform. This probing book examines the implications of our reliance on China on the quality and availability of vital medicines. von Gibson, Rosemary und Singh, Janardan Prasa
Produktdetails

So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
- Kartoniert
- 288 Seiten
- Erschienen 2017
- I.B. Tauris
- Gebunden
- 720 Seiten
- Erschienen 2016
- Phaidon Press
- Taschenbuch
- 384 Seiten
- Erschienen 2018
- Guilford Publications
- Hardcover
- 776 Seiten
- Erschienen 2009
- Springer US
- Taschenbuch
- 200 Seiten
- Erschienen 2020
- I.B. Tauris
- Gebunden
- 304 Seiten
- Erschienen 2022
- Polity
- hardcover
- 224 Seiten
- Erschienen 2010
- Economist Books
- hardcover
- 274 Seiten
- Erschienen 2005
- Page One Publishing
- paperback
- 300 Seiten
- Erschienen 2010
- Wspc
- paperback
- 236 Seiten
- Erschienen 2005
- Oecd Publishing